Alain Lalé

The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the Rabbit

Frédérique Dol, A. Bernat, Robert Falotico et al. · Thrombosis and Haemostasis · 1998 · 163 citations

Medicine, Pharmacology, Pharmacotherapy +17

New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists:  Identification of Ethyl 3-[<i>N</i>-[4-[4-[Amino[(ethoxycarbonyl)imino]methyl]phenyl]- 1,3-thiazol-2-yl]-<i>N</i>-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent

Alain Badorc, Marie-Françoise Bordes, P. DE COINTET et al. · Journal of Medicinal Chemistry · 1997 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

SSR182289A, a Novel, Orally Active Thrombin Inhibitor: In Vitro Profile and ex Vivo Anticoagulant Activity

Christopher N. Berry, Gilbert Lassalle, Catherine Lunven et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 22 citations

Medicine, Hematology, Pharmacology +17

SR 121787, a New Orally Active Fibrinogen Receptor Antagonist

Pierre Savi, Alain Badorc, Alain Lalé et al. · Thrombosis and Haemostasis · 1998 · 16 citations

Medicine, Hematology, Pharmacology +17

Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes

Jean‐Marc Herbert, Pierre Savi, Alain Lalé et al. · Biochemical Pharmacology · 1994 · 15 citations

Veterinary Medicine, Cell Biology, Immunology +14